Sphera Funds Management Ltd. Regeneron Pharmaceuticals, Inc. Transaction History

Sphera Funds Management Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$273.46 - $318.39 $8.2 Million - $9.55 Million	-30,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $8.99 Million - $12.4 Million	30,000 New	30,000 $0
Q2 2018 Aug 13, 2018	SELL	$284.6 - $344.99 $11.8 Million - $14.3 Million	-41,500 Closed	0 $0
Q1 2018 May 10, 2018	BUY	$315.82 - $393.78 $13.1 Million - $16.3 Million	41,500 New	41,500 $14.3 Million

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.6B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.